IMPACT (IMproving Patient Access to Cancer Clinical Trials) by Lazarex Cancer Foundation-IMPACT is a 3-year pilot study with a comprehensive approach to improving patient enrollment, retention, minority participation and equitable access in oncology trials.
Lazarex Cancer Foundation improves the outcome of cancer care, giving hope, dignity and life to advanced stage cancer patients and the medically underserved by providing assistance with costs for FDA clinical trial participation, identification of clinical trial options, community outreach and engagement. Clinical trials are the capstone of the drug development process and the vehicle our FDA uses to bring new drugs to market safely. Patient participation is critical to the successful completion of a trial. Clinical trials offer medical breakthrough opportunities available today to advanced stage cancer patients who have no other treatment options. Most often, health insurance doesn’t cover the prohibitive ancillary costs. Lazarex is the last safety net for these patients until we find a cure.